Zobacz książki o podobnej tematyce

Więcej informacji o Integration of Pharmaceutical Discovery and Development

• Dane szczegółowe
• Opis
• Ulubione w innej kategorii

Za ten zakup dostaniesz 603 punkty

Opis

In the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would not produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- maceutical (e. g. , cell membrane permeability), and metabolic/pharmacokinetic (e. g. , metabolic stability, clearance, and protein binding) properties. Successful implementation of this strategy requires a multidisciplinary team effort, incl- ing scientists from drug design (e. g. , medicinal chemists, cell biologists, en- mologists, pharmacologists) and drug development (e. g. , analytical chemists, pharmaceutical scientists, physiologists, and molecular biologists representing the disciplines of pharmaceutics, biopharmaceutics, and pharmacokinetics/drug metabolism). With this new, highly integrated approach to drug design now widely utilized by the pharmaceutical industry, the editors of this book have provided the sci- tific community with case histories to illustrate the nature of the interdisciplinary interactions necessary to successfully implement this new approach to drug d- covery. In the first chapter, Ralph Hirschmann provides a historical perspective of why this paradigm shift in drug discovery has occurred.

Szczegóły książki

Kategoria Książki po angielsku Mathematics & science Biology, life sciences Zoology & animal sciences

• Pełny tytuł: Integration of Pharmaceutical Discovery and Development
• Podtytuł: Case Histories
• Autor: Ronald T. Borchardt, Roger M. Freidinger, Tomi K. Sawyer, Philip L. Smith
• Język: Angielski
• Oprawa: Twarda
• Liczba stron: 610
• EAN: 9780306457432
• ISBN: 0306457431
• ID: 03612056
• Wydawca: Springer Science+Business Media
• Waga: 1068 g
• Wymiary: 229 × 152 × 39 mm
• Data wydania: 31. August 1998

Ulubione w innej kategorii

---

---

---